Research Article

Estimating global case fatality rate of coronavirus disease 2019 (COVID-19) pandemic

Shyamapada Mandal* and Manisha Mandal

Published: 11 August, 2020 | Volume 3 - Issue 1 | Pages: 036-039

Background: There is a huge global loss of lives due to COVID-19 pandemic, the primary epicentre of which is China, where the causative agent of the disease, SARS-CoV-2 was first emerged in December 2019. This study aims to explore the severity, in terms of case fatality rate (CFR), of COVID-19 pandemic.

Methods: Data of ongoing COVID-19 global pandemic were retrieved from website of the WHO, and processed for the estimation of global (both including and excluding China) CFRs of COVID-19. CFRs were explored following the naive estimates, 14-day delay estimates, and linear regression model analysis, during January 25, 2020 to April 25, 2020, on weekly basis. To explore the current situation, in terms of CFR, data for the next 13 weeks (May 2, 2020 through July 25, 2020), were processed by naive and linear regression model analysis.

Results: Mean CFRs, in naive estimates, were 4.59% for the world including China, and 3.62% for the world excluding China. The 14-day delay estimates of CFRs were 15.6% globally, and 21.65% in countries outside China. Following statistical model, global (both including and excluding China) CFRs were 6.81%, by naive estimates, and ~13%, by 14-day delay estimates. Global CFRs of COVID-19 during May 2, 2020 to July 25, 2020, ranged 4.1% – 7.04%, by naive estimates, and by statistical regression analysis the CFR was 3.19%.

Conclusion and recommendations: The CFR might help estimate the need of up-to-date hospital supplies and other mitigation measures for COVID-19 ongoing pandemic, and therefore, instantaneous CFR estimations are recommended.

Read Full Article HTML DOI: 10.29328/journal.ijcmbt.1001014 Cite this Article Read Full Article PDF


COVID-19 pandemic; SARS-CoV-2; Case fatality rate; Global including china; Global excluding china


  1. World Health Organization. Coronavirus disease (COVID-2019) situation reports. WHO 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/
  2. Zhou P, Yang X, Wang X, Hu B, Zhang L, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579: 270-273. PubMed: https://pubmed.ncbi.nlm.nih.gov/32015507/
  3. Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol. 2020; 49: 717-726. PubMed: https://pubmed.ncbi.nlm.nih.gov/32086938/
  4. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239-1242. PubMed: https://pubmed.ncbi.nlm.nih.gov/32091533/
  5. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March. WHO 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19/
  6. Tsai J, Wilson M. COVID-19: a potential public health problem for homeless populations. Lancet Public Health 2020; 5: E186-E187. PubMed: https://pubmed.ncbi.nlm.nih.gov/32171054/
  7. European Centre for Disease Prevention and Control. COVID-19 situation update worldwide, as of 27 July 2020. ECDC 2020. https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases/
  8. Giangreco G. Case fatality rate analysis of Italian COVID-19 outbreak. J Med Virol 2020; 92: 919-923. PubMed: https://pubmed.ncbi.nlm.nih.gov/32297983/
  9. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, et al. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 20; 2020: 773. PubMed: https://pubmed.ncbi.nlm.nih.gov/32171390/
  10. Linton NM, Kobayashi T, Yang Y, Hayashi K, Akhmetzhanov AR, et al. Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: A statistical analysis of publicly available case data. J Clin Med. 2020; 9: 538. PubMed: https://pubmed.ncbi.nlm.nih.gov/32079150/
  11. Yang S, Cao P, Du P, Wu Z, Zhuang Z, et al. Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis. Ann Transl Med 2020; 8: 128. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049028/
  12. Oztoprak F, Javed A. Case fatality rate estimation of COVID-19 for European countries: Turkey’s current scenario amidst a global pandemic; comparison of outbreaks with European countries. EJMO 2020; 4: 149–159.
  13. Wilson N, Kvalsvig A, Barnard LT, Baker GM. Case-fatality estimates for COVID-19 calculated by using a lag time for fatality. Emerg Infect Dis 26; 2020:1339-1441. PubMed: https://pubmed.ncbi.nlm.nih.gov/32168463/
  14. Lipsitch M. Estimating case fatality rates of COVID-19. Lancet Infect Dis 20; 2020: 774–775.
  15. Spychalski P, Błazynska-Spychalska A, Kobiela J. Estimating case fatality rates of COVID-19. Lancet Infect Dis 20; 2020: 775. PubMed: https://pubmed.ncbi.nlm.nih.gov/32243815/
  16. Jiang S. Don’t rush to deploy COVID-19 vaccines and drugs. Nature 579; 2020: 321. PubMed: https://pubmed.ncbi.nlm.nih.gov/32179860/
  17. Harrison C. Coronavirus puts drug repurposing on the fast track. Nature Biotechnol 2020; 38: 379-381. PubMed: https://pubmed.ncbi.nlm.nih.gov/32205870/
  18. Mandal S, Bhatnagar T, Arinaminpathy N, Agarwal A, Chowdhury A, et al. Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach. Indian J Med Res 2020; 151: 190-199. PubMed: https://pubmed.ncbi.nlm.nih.gov/32362645/
  19. Mandal M, Mandal S. Phasic containment of COVID-19 in substantially affected states of India. medRxiv 2020.
  20. Mandal M, Mandal S. COVID-19 pandemic scenario in India compared to China and rest of the world: a data driven and model analysis. medRxiv 2020.
  21. Mia Y, Huanga T, Zhanga J, Qina Q, Gonga Y, et al. Estimating the instant case fatality rate of COVID-19 in China. Int J Infect Dis. 97; 2020: 1–6. PubMed: https://pubmed.ncbi.nlm.nih.gov/32339723/
  22. Sudharsanan N, Didzun O, Barnighaausen T, Geldsetzer P. The contribution of the age distribution of cases to COVID-19 case fatality across countries. Ann Intern Med. 2020; M20-2973. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397549/


Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More